Inactief instrument

Andere talen Orchid Pharma Limited Bombay S.E.

Aandelen

524372

INE191A01019

Andere talen

Krijg toegang tot al het nieuws: wees als eerste op de hoogte en reageer voordat de beurs dat doet!

Orchid Pharma Gets Indian Regulator's Nod for Enmetazobactam	06/06
Orchid Pharma Receives DCGI Approval for Its First Invented and Made-In-India Antibiotic Drug Combination of Cefepime and Enmetazobactam	06/06
Orchid Pharma Limited Appoints Shubha Singh as Additional Director	23/05
Orchid Pharma Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024	23/05
PUFE Transactions Under IBC	14/05
Orchid Pharma Limited Receives Order from Office of Assistant Commissioner Valluvarkottam Central-III Chennai Central	02/05
Orchid Pharma Limited Announces Resignation of Mudit Tandon as Independent Director	12/04
Orchid Pharma : Iii. Un-audited Financial Results for the quarter ended December 31, 2023 - Dec 31,2023	12/04
Orchid Pharma : Un-audited Financial Results for the quarter ended June 30, 2023 - June 30,2023	12/04
Orchid Pharma : Un-audited Financial Results for the quarter and half year ended September 30, 2023 - Sep 30,2023	12/04
Orchid Pharma Receives United States Food and Drug Administration Approval for Its Novel Invention	23/02
Orchid Pharma Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	08/02
European Medicines Agency Grants Approval for Orchid Pharma's 'Exblifep'	30/01
Orchid Pharma Limited Appoints Kapil Dayya as Company Secretary & Compliance Officer	16/12
Orchid Pharma Limited Announces Resignation of Marina Peter as Company Secretary and Compliance Officer	14/12
Orchid Pharma Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	04/11
Orchid Pharma Limited Approves the Appointment of Mr. Arjun Dhanuka as Additional Director (In Capacity of Non-Executive & Non-Independent)	20-10-23
Orchid Pharma Ties Up with GARDP to Manufacture Antibiotic for Certain Gram-Negative Infections	12-09-23
Orchid Pharma Limited Enters into Manufacturing Sub License Agreement with Global Antibiotic Research & Development Partnership	12-09-23
Orchid Pharma Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	10-08-23

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Orchid Pharma Limited Bombay S.E.

Aandelen

524372

INE191A01019

Andere talen

Filters